A multimodal single-cell framework for ecosystem-level profiling of circulating tumor and non-tumor cells

Multimodal profiling of circulating tumor cells (CTCs) and non-tumor circulating cells was performed in six patients with advanced colorectal cancer to identify biological programs beyond enumeration-based analyses. Across all patients, we identified 3,981 CTCs characterized by pronounced EpCAM/L1CAM co-expression, variable PD-L1 expression, and low LGR5 expression, consistent with metastatic-associated phenotypes. Integrated single-cell multi-omics analysis of 1,720 cells revealed genomic instability within EpCAM⁺, L1CAM⁺, LGR5⁺, and PD-L1⁺ CTC subsets, including Y-chromosome loss in male patients and marked intra-patient heterogeneity. In parallel, non-CTCs exhibited upregulation of inflammatory and metabolic dysregulation programs. This hypothesis-generating study highlights the relevance of blood-based multimodal single-cell profiling for interrogating tumor-host states beyond insights from CTC enumeration alone.

Authors

Institutions

Publication Details

Journal
Experimental Hematology and Oncology
Published
2026-06-19
DOI
https://doi.org/10.1186/s40164-026-00796-y
Primary Topic
Cancer Cells and Metastasis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A multimodal single-cell framework for ecosystem-level profiling of circulating tumor and non-tumor cells

Rocio Alvarez, Lisa Zhou, Megan P. Hitchins, Aaron Denmark et al.
Experimental Hematology and Oncology
Cancer Cells and Metastasis
article

A multimodal single-cell framework for ecosystem-level profiling of circulating tumor and non-tumor cells

Rocio Alvarez, Lisa Zhou, Megan P. Hitchins, Aaron Denmark, Jun Gong, Daniel M. Kim, Francesca Aguirre, Gabriela Felix
article en

Abstract

Multimodal profiling of circulating tumor cells (CTCs) and non-tumor circulating cells was performed in six patients with advanced colorectal cancer to identify biological programs beyond enumeration-based analyses. Across all patients, we identified 3,981 CTCs characterized by pronounced EpCAM/L1CAM co-expression, variable PD-L1 expression, and low LGR5 expression, consistent with metastatic-associated phenotypes. Integrated single-cell multi-omics analysis of 1,720 cells revealed genomic instability within EpCAM⁺, L1CAM⁺, LGR5⁺, and PD-L1⁺ CTC subsets, including Y-chromosome loss in male patients and marked intra-patient heterogeneity. In parallel, non-CTCs exhibited upregulation of inflammatory and metabolic dysregulation programs. This hypothesis-generating study highlights the relevance of blood-based multimodal single-cell profiling for interrogating tumor-host states beyond insights from CTC enumeration alone.

Experimental Hematology and OncologyVol. 15(1)
Cedars-Sinai Medical Center (US), Moffitt Cancer Center (US)
Conquer Cancer Foundation, American Society of Clinical Oncology, Cedars-Sinai Medical Center, National Cancer Institute
Life in Land
Openalex Percentile: Top 9%
Cancer Cells and Metastasis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.